Global Cell Culture Market Set to Soar to $48.63 Billion by 2029, Driven by Strong Growth in Biopharma and Rising Demand for Monoclonal Antibodies

"Global Cell Culture Market Set to Soar to $48.63 Billion by 2029, Driven by Strong Growth in Biopharma and Rising Demand for Monoclonal Antibodies J

Cell Culture Market 2022-2029 Meticulous Research , a global leader in market research and consulting services, has released its latest comprehensive report titled, Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell Research, Diagnostic), End User (Pharma, Academic) - Global Forecast to 2029. The report reveals that the global cell culture market is projected to grow at a robust CAGR of 11.7% from 2022 to 2029, reaching a valuation of $48.63 billion by 2029. Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample- report/cp_id=4788?utm_source=article&utm_medium=social&utm_campaign =product&utm_content=17-09-2024 The upward trajectory of the cell culture market is being driven by several key factors, including the rapid expansion of the biopharmaceutical sector, increasing incidence of chronic diseases, growing demand for monoclonal antibodies, increased research funding, and the rising adoption of single-use technologies in cell culture processes. Furthermore, the growing acceptance of 3D cell culture models and advancements in personalized medicine are poised to create new growth opportunities for stakeholders in this space. Impact of COVID-19 Pandemic on Cell Culture Research Activities The COVID-19 pandemic has had a significant and positive impact on cell culture-based research activities. During the early stages of the pandemic, understanding the transmission kinetics and biological behavior of the virus became critical to devising effective control strategies. Researchers worldwide embarked on extensive studies to explore how new drugs could inhibit viral replication and how vaccines could elicit effective immune responses. These studies relied heavily on in vitro cell culture models, which played a pivotal role in the development of vaccines, treatments, and diagnostic tools. The availability of SARS-CoV-2 virus strains, such as the one distributed by the Centers for Disease Control and Prevention (CDC) to research institutions globally in February 2020, accelerated these efforts. Human lung epithelium models, among other cell culture models, proved essential in COVID-19 research, aiding investigations in antiviral research, vaccine development, and virus pathogenesis. Market Segmentation and Key Insights Page 1 of 4 Meticulous Research| sales@meticulousresearch.com

Cell Culture Market 2022-2029 The cell culture market is divided into several segments based on product type, application, end-user, and geography, providing an in-depth analysis for investors and market participants. Product Segmentation: Consumables Lead the Way The market is segmented into two primary categories: consumables and equipment. In 2022, consumables comprising media, reagents, sera, cell lines, and cell culture vessels accounted for the largest market share. The frequent need for consumables across various stages of the cell culture process has made them indispensable to laboratories and production facilities worldwide. Consumables such as growth factors, cytokines, serum-free media, and other reagents are essential for facilitating the development of biological products, which continue to see heightened demand. Application Segmentation: Bioproduction as a Growth Driver Based on application, the bioproduction segment dominated the market in 2022. The increasing global demand for biopharmaceuticals, including monoclonal antibodies, vaccines, therapeutic proteins, and cell and gene therapies, has been the key driver for this segment's growth. Cancer research, drug screening, and stem cell research are other major application areas where cell culture techniques are gaining prominence, further expanding the market. End-User Segmentation: Pharmaceutical & Biotechnology Companies Hold a Major Share Among end-users, pharmaceutical and biotechnology companies represented the largest market share in 2022. This growth can be attributed to the presence of leading biotech companies, a rise in start-ups, and increased investments in expanding production and cell culture capabilities. Additionally, academic & research institutes remain a critical segment, as academic collaborations and government funding fuel research in cell culture technologies. Regional Analysis: North America Leads the Market Geographically, North America is projected to maintain its leading position in the cell culture market throughout the forecast period. This dominance is supported by a well- established healthcare infrastructure, rapid adoption of cutting-edge technologies, and a high prevalence of non-communicable diseases requiring advanced biopharmaceutical treatments. In addition, the biopharma sector in the U.S. and Canada is continuously Page 2 of 4 Meticulous Research| sales@meticulousresearch.com

Cell Culture Market 2022-2029 expanding its production capacity, further bolstering the cell culture market in the region. Europe and Asia-Pacific are also significant players, with the latter expected to witness notable growth due to increasing investments in research and biopharmaceutical manufacturing. Key Players Driving Market Innovation Prominent companies at the forefront of the global cell culture market include: Merck KGaA (Germany) Thermo Fisher Scientific Inc. (U.S.) Cytiva (U.S.) Lonza Group Ltd. (Switzerland) Corning Incorporated (U.S.) Becton, Dickinson and Company (U.S.) Avantor, Inc. (U.S.) Bio-Rad Laboratories, Inc. (U.S.) HiMedia Laboratories (India) Sartorius AG (Germany) Eppendorf SE (Germany) FUJIFILM Holdings Corporation (Japan) Agilent Technologies, Inc. (U.S.) Getinge AB (Sweden) These key players continue to innovate and invest in cutting-edge technologies, driving advancements in the cell culture space and addressing the growing demand for efficient, high-quality cell culture systems. Page 3 of 4 Meticulous Research| sales@meticulousresearch.com

Cell Culture Market 2022-2029 Conclusion The cell culture market is poised for exponential growth, driven by advancements in biopharmaceutical production, increasing demand for monoclonal antibodies, and the rising prevalence of chronic diseases. As companies continue to innovate and expand their cell culture capabilities, the market is expected to reach new heights, offering lucrative opportunities for stakeholders across the pharmaceutical, biotech, and research sectors. Quick Buy @ https://www.meticulousresearch.com/Checkout/94004198?utm_source=articl e&utm_medium=social&utm_campaign=product&utm_content=17-09-2024 About Meticulous Research Meticulous Research was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze, and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth. Contact Us: Meticulous Research Email- sales@meticulousresearch.com Contact Sales- +1-646-781-8004 Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research Page 4 of 4 Meticulous Research| sales@meticulousresearch.com